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Summary 
The development of autoimmune diabetes in the nonobese diabetic (NOD) mouse is controlled 
by multiple genes. At least one diabetogenic gene is linked to the major histocompatibility complex 
(MHC) of the NOD and is most likely represented by the two genes encoding the c~ and 
chains of the unique NOD class II molecule. Three other diabetogenic loci have recently been 
identified in the NOD mouse and are located on chromosomes 1, 3, and 11. In addition to the 
autoimmune diabetes which is caused by destruction of  the insulin-producing B cells in the pancreas, 
other manifestations of autoimmunity are seen in the NOD mouse. These include mononuclear 
cell inflammation of the submandibular and lacrimal glands, as well as the presence of circulating 
autoantibodies. To determine the effect of the non-MHC diabetogenic genes on the development 
of autoimmunity, we constructed the NOD.B10-H-2 b (NOD.H-2  b) strain, which possesses the 
non-MHC diabetogenic genes from the NOD mouse, but derives its MHC from the C57BL/10 
(B10) strain.  The  NOD.H-2  ~ strain  does  not  develop  insulitis,  cyclophosphamide-induced 
diabetes, or spontaneous diabetes. It does, however, develop extensive lymphocytic infiltrates in 
the pancreas and the submandibular  glands that are primarily composed of Thy 1.2 + T  cells 
and B220 + B cells. In addition,  autoantibodies are present in NOD.H-2  ~ mice which recognize 
the "polar antigen" on the insulin-secreting  rat tumor line RINm38. These observations demonstrate 
that the non-MHC genes in the NOD strain, in the absence of the NOD MHC, significantly 
contribute to the development of autoimmunity. The contribution of a single dose of the NOD 
MHC to autoimmunity was assessed with a (NOD  x  NOD.H-2b)F1 cross. Although only 
'~3% of F1 females developed spontaneous diabetes, approximately 50% of both female and male 
F1 mice developed insulitis, and 25%  of females and 17% of males became diabetic after treat- 
ment with cyclophosphamide. These data demonstrate that the MHC-linked diabetogenic genes 
of the NOD mouse are dominant with decreasing  levels of penetrance for the following phenotypes: 
insulitis  >  cyclophosphamide-induced  diabetes >  spontaneous  diabetes. 
T 
he nonobese diabetic (NOD)  1 mouse spontaneously de- 
velops autoimmune diabetes and is an experimental model 
of human type I diabetes. We previously determined in out- 
1  Abbreviation used in this paper: NOD, nonobese  diabetic. 
crosses to the C57BL/10 (B10) strain, that at least one gene 
linked to the MHC of the NOD and three non-MHC-linked 
recessive  diabetogenic genes present in the NOD mouse were 
required for the development of diabetes (1). Recently, using 
an outcross with the B10.NOD-H-2g 7 (B10.H-2g  7) strain (a 
B10 congenic mouse whose MHC was derived from the NOD 
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-5, on chromosomes 3,  11, and 1, respectively (2,  3).  It is 
interesting that each of these diabetogenic genes did not func- 
tion in a strictly recessive manner, but rather as dominant 
genes with reduced penetrance. 
In other studies involving outcrosses of the NOD to the 
C3H and nonobese nondiabetic (NON) strains of mice, the 
MHC-linked diabetogenic gene of the NOD mouse appeared 
to function in an absolutely recessive manner since only NOD 
MHC (H-2F) homozygotes became diabetic (4). In contrast, 
in backcross generations of (NOD  x  B10) outcrosses to the 
NOD parental strain,  a small percentage of H.2F/b MHC 
heterozygotes became diabetic (1, 5). Analysis of the preva- 
lence of  diabetes in offspring produced from one diabetic MHC 
heterozygote supported the hypothesis that the low incidence 
of  diabetes in MHC heterozygotes was not due to a rare recom- 
bination event, but was due to a low penetrance of a dom- 
inant MHC-linked diabetogenic gene in the heterozygous state 
(5). Insulitis was also observed in many MHC heterozygotes 
in the backcross generations, suggesting that homozygosity 
at the NOD MHC was not required for manifestations of 
subclinical  autoimmunity. To assess the roles of the MHC- 
associated and the non-MHC diabetogenic genes in the au- 
toimmune pathogenesis of the NOD mouse, we developed 
a  MHC  congenic  strain  on  the  NOD  background,  the 
NOD.H-2  b,  where  the MHC  has been  derived from the 
normal B10 strain. 
Materials and Methods 
Animals.  A breeding nucleus of inbred NOD mice was kindly 
provided by Dr. Yoshihiro Tochino (Aburabi Laboratories,  Shionogi 
and Co., Osaka,  Japan). After Cesarean  derivation,  our NOD colony 
(NOD/MrkTacfBR) was maintained by brother-sister mating at 
Taconic Farms (Germantown, NY). NOD mice at both Taconic 
Farms and Merck were housed under sterile, specific  pathogen-free 
conditions. 
NOD mice (K  d, I-A  n~  D  s, and no expression of I-E) were out- 
crossed to C57BL/10SnJ mice (K  b, I'A b, D s,  and no expression 
of I-E) obtained from The Jackson Laboratory (Bar Harbor, ME), 
and the resulting F1 mice backcrossed to the NOD parental strain 
as reported earlier (5). Breeders were selected for the expression 
of I-A  s on the surface of PBMC. Generally, MHC heterozygous 
females were backcrossed to NOD males for each backcross gener- 
ation. At the fifth (N6) and eleventh (N12) backcross generations, 
an intercross  was made using male and female  MHC heterozygotes. 
Intercross mice that were homozygous for the K  s and I-A  b pheno- 
types were used to initiate the NOD.H-2 ~ inbreeding. 
MHC TyFing.  Dissociated spleen cells or peripheral blood cells 
were incubated with the following mAbs to determine the MHC 
phenotype: mouse mAb 10-2.16 (6) (TIB 93; American Type Cul- 
ture Collection [ATCC], Rockville, MD) which is reactive with 
1-A  n~  but not I-A  s, rat mAb M5/114.15.2 (7) (TIB120, ATTC) 
which is reactive with I-A  b but not I-A  ~~  mouse mAb anti-K  d 
(SF1-1.1) (PharMingen, San Diego, CA), and mouse mAb 34-4- 
20S (8) (Litton Bionetics, Charleston, SC) which reacts with K  s 
but not K  d antigens. After incubation with the various mAbs for 
20 rain at 4~  the cells were washed and then incubated for 20 
rain  with the appropriate counterstain:  FITC-conjugated goat 
anti-mouse IgG (9) or FITC-conjugated  monodonal anti-rat ir chain 
(AMAC, Inc., Westbrook,  ME). Cells  were analyzed  by flow cytom- 
etry (FACS  |  IV; Becton Dickinson & Co., Mountain View, CA). 
Propidium iodide was added to exclude dead cells. 
Histology.  Pancreata  and submandibuhr glands were either fixed 
in buffered 10% formalin and processed for paraffin embedding 
or were frozen in isopentane cooled with liquid nitrogen. Paraffin 
sections (5 t~) obtained from three noncontiguous tissue levels were 
stained with hematoxylin and eosin and examined for evidence of 
histological abnormalities. The phenotypic composition of the 
infiltrating lymphocytes observed in frozen sections (5 t~) was de- 
termined by immunoperoxidase histochemistry using biotinylated 
mAbs spedfic for the call surface antigens Thy 1.2 and B220, as 
previously described (10). 
Deteaion of  Autoantibodies Recognizing the ~lar Antigen.  Cryostat 
sections (5 I*) of  the transphntable rat insulinoma tumor RINm38 
grown in New England Deaconess Hospital rats were fixed in ace- 
tone for 10 rain at 20~  followed by absolute methanol for 10 
rain at 20~  and then air-dried. Fixed sections were rehydrated 
in 0.05 M Tris buffer (pH 7.4) containing 0.9% saline (Tris-saline) 
for 20 rain at 20~  and then incubated for 1 h at 20~  with 30 
~1 of serum diluted 1:5 in Tris-saline containing 1% BSA. Tissue 
sections were washed three times with Tris-saline  buffer for a total 
of 10 rain at 20~  and incubated for 1 h at 20~  with peroxidase 
conjugated protein A (Boehringer Mannheim Biochemicals,  Indi- 
anapolis, IN) diluted 1:100 in Tris-saline  buffer. Antibody binding 
was developed colorimetrically by the addition of diaminobenzi- 
dine tetrachloride (0.5 mg/ml) (Sigma Chemical Co., St. Louis, 
MO) dissolved in Tris-saline buffer containing 0.001% hydrogen 
peroxide. After washing, the slides  were mounted with AFT systems 
mounting medium (Behring Diagnostics, La Jolla, CA). 
CFlophosphamide Treatment.  Cytoxan (cyclophosphamide  for in- 
jection, USP) was purchased and prepared according  to the manufac- 
turer's instructions (Mead  Johnson Oncology Products, Evansville, 
IN). Lyophilized  cytoxan was prepared for use immediately before 
injection by adding sterile distilled water for a final concentration 
of 20 mg/ml. Mice received 200 mg/kg by intraperitoneal injec- 
tion on days  0 and 14. All mice were nondiabetic before treatment, 
and diabetes was monitored on a weekly basis up to day 28 after 
the first injection. 
Results 
Establishment of the !VOL~H-2  b Strain.  After an outcross 
of the NOD strain to the B10 strain, repetitive backcrosses 
with NOD were performed with breeder selection based on 
the  expression  of  I-A  b  as  described  in  Materials  and 
Methods. At the N6 generation, and later at the N12 gener- 
ation, an intercross was performed to fix the 1-1-2  b haplotype 
on the NOD background. A representative MHC typing ex- 
periment (Fig.  1) demonstrates that the NOD.H-2  b strain 
expresses K b and I-A  b, and is negative for NOD MHC class 
I and II antigens. Mice that were homozygous for the B10 
MHC at the fifth (N6) and eleventh (N12)  backcross inter- 
cross generations were used to establish the NOD.H-2  b (N6) 
and NOD.H-2  b (N12) strains, respectively, which were then 
maintained by brother-sister mating. 
Prevalence of Diabetes in NOEtH-2 b Mice.  We have previ- 
ously shown that by the N4 generation, the prevalence  of 
diabetes  in the NOD MHC homozygotes had reached fre- 
quencies observed in the NOD parental strain in our colony 
(5).  These results imply that by the N4 generation, non- 
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Figure  1.  Spleen cells from NOD,  NOD.H-2  b, and B10 mice were 
tested for the presence of the K  b and K  a class I antigens and the I-A  b and 
I-A  n~  class II antigens as described in Materials and Methods. Each histo- 
gram includes the staining pattern obtained with the relevant counterstain 
(dashed lines). 
MHC-linked  recessive diabetogenic  genes must  have been 
fixed in the backcross population. Therefore, it is reasonable 
to assume that the non-MHC-linked recessive diabetogenic 
genes are also present in the NOD.H-2 b strains fixed at the 
N6 and N12 generations. Additional support for this hypoth- 
Table  1.  Incidence of Diabetes in the NOD.H-2  b N6 and 
N12 Intercross Generations 
No.  diabetic/total  observed 
MHC  N6 female  N6  male  N12 female  N12 male 
NOD/NOD  7/9  (78%)  1/6  (17%)  5/5  (100%)  5/10  (50%) 
NOD/b  0/13  0/15  0/10  0/10 
b/b  0/7  0/6  0/6  0/1 
MHC heterozygous mice from the fifth (N6) and eleventh (N12) back- 
cross generations were intercrossed and the MHC type of the resulting 
progeny was determined. Intercross progeny were observed for the on- 
set of diabetes for 8-12 too. 
esis comes from the incidence of diabetes in the N6 and N12 
intercross generations (Table 1). As anticipated, the frequen- 
cies of diabetes in NOD MHC homozygous females and males 
were not different from those observed in NOD  females and 
males in our colony (80 and 50%, respectively). No sponta- 
neous  diabetes  was  observed  in  either  the  NOD.H-2 ~ or 
(NOD  x  NOD.H-2~)F1  mice  present  in  the  N6  or  N12 
generations.  In addition,  no diabetes was observed among 
more than 100 female and 100 male NOD.H-2 b mice moni- 
tored for a minimum of 1 yr (data not  shown).  We previ- 
ously reported (1, 5) a low incidence (~3%) of spontaneous 
diabetes in female (NOD  x  NOD.H-2b)Ft  mice,  and pre- 
sumably did not observe any diabetics in this population in 
the current  study because of its relatively small size (Table 
1,  n  =  23). 
Pancreatic and Submandibular Gland Pathology  in NOLaH-2 b 
M/c~  Table 2 summarizes the pathology observed in the pan- 
creata and submandibular  glands of 22 female and 20 male 
Table  2.  Pancreatic and Submandibular Gland Pathology in NOD.H-2 ~ Mice 
Pancreas  score  Submandibular  gland  score 
0  1  2  3  4  0  1  2  3 
Females  2/22  8/22  11/22  1/22  0/22  0/22  1/22  7/22  14/22 
(9%)  (36~  (50~  (5070)  (0070)  (0070)  (5070)  (32070)  (64070) 
Males  3/20  14/20  3/20  0/20  0/20  0/20  2/20  14/20  4/20 
(15070)  (70070)  (15070)  (0070)  (0070)  (0070)  (10070)  (70070)  (2007o) 
NOD.H-2  b (N6) mice were examined between 7 and 11 mo of age. None of the mice were diabetic. Three noncontiguous H and E stained sections 
of pancreas were examined by light microscopy for evidence of mononuclear cell inflammation. Histology scoring criteria: 0, no inflammatory cells 
present in the pancreas; 1, infiltrating cells observed in periductal and/or perivascular locations; 2, inflammatory cells observed at islet periphery; 
3, mild inflammation of the islet in which <25% of the islet area contains infiltrating cells; and 4, moderate to severe inflammation of the islet. 
Classification of each animal was made using the most severe inflammatory lesion observed. For the examination of submandibular glands, three 
noncontiguous H and E stained sections were examined by light microscopy for evidence of mononuclear cell inflammation. Histology scoring crite- 
ria: 0, no inflammatory cells present; 1, mild inflammatory response in which only small accumulations of lymphoid cells are observed within the 
submandibular gland; 2, moderate inflammatory response in which multiple large periductal loci are observed; and 3, massive inflammatory response 
in which  a majority  of the submandibular gland is affected. 
69  Wicker et al. 70  Autoimmunity in NOD.H-2  b and (NOD  ￿  NOD.H-2b)F~ Mice Figure 2.  Pancreatic  histology of the NOD.H-2  b mouse. (A) Massive  perivascular and periductal infiltration by mononudear cells; (/3) perivascular 
and periductal lymphocytic infiltrates proximal to an islet; and (C) mild insulitis. Hematoxylin and eosin, A (x125), B (x200), C (x200). 
NOD.H-2 s (N6)  mice between  7  and  11  mo of age.  Peri- 
ductal and perivascular lymphoid infiltrates (Fig. 2 A) were 
frequently seen in the pancreas of both female and male mice 
with females generally developing more severe inflammation. 
Such inflammation was often extensive and in close prox- 
imity to islets (Fig. 2 B), although insulitis, a lymphocytic 
invasion of the islets present in almost all NOD  mice, was 
only occasionally observed (Fig.  2  C).  When insulitis was 
Figure 3.  Immunohistoehemical  analysis  of an 
NOD.H-2  ~ mouse pancreas. Cryostat sections 
were incubated  with biotinylated  anti-Thy  1.2 fol- 
lowed  by streptavidin  conjugated  with horseradish 
peroxidase  to demonstrate  T lymphocytes  (x 200). 
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was affected in  an individual  NOD.H-2  b mouse. 
The phenotypic composition of the pancreatic infiltrates 
was determined in selected mice with established lesions and 
was found to contain  a mixture  of Thy  1.2 + (Fig.  3) and 
B220 + (results  not  shown)  lymphocytes.  It is  noteworthy 
that the lymphocytic infiltrates  observed within the pancreata 
of NOD.H-2  b mice were not seen in the parental B10 strain. 
The NOD.H-2  b infiltrates  do, however, resemble those in the 
NOD mouse except that in NOD mice the lymphocytes in- 
vade the islets and  selectively destroy the B  cells,  whereas 
in NOD.H-2  b mice, the infiltrates  rarely penetrate the islets. 
To evaluate the influence of age on the frequency and severity 
of insulitis  in NOD.H-2  b mice, pancreata  from ten  16-mo- 
old female NOD.H-2  b (N6) mice were examined.  Only one 
islet from one of the ten mice examined displayed a mild form 
of insulitis.  These data suggest that the frequency and severity 
of insulitis  does  not  progressively  intensify  with  age  in 
NOD.H-2  b mice. 
Sialitis,  loci of periductal lymphocytic infiltration  in the 
submandibular glands, has been reported in NOD mice and 
could be transferred to syngeneic NOD neonates by splenic 
T cells (11, 12). Sialitis is also detected in most NOD mice from 
our colony by 6 mo of age and is not sex-restricted. We noted 
similar inflammatory responses in the submandibular glands 
of NOD.H-2  b mice with lesions being more severe in females 
(Fig.  4) than in males.  Multifocal lymphoid accumulations 
assodated with large ductuhr elements were seen in the mixed 
serous-mucous glands of submandibular tissues. It is interesting 
that  sialitis  was not encountered in those portions  of sub- 
mandibular tissue comprised of either purely serous or mu- 
cous glandular  components.  Like the pancreatic inflamma- 
tory lesions,  Thy-l.2 +  and  B220 +  calls  were the  primary 
constituents  of the submandubular  gland  infiltrates  of the 
NOD.H-2  b strain (results not shown). In contrast, although 
occasional small lymphoid accumulations  were seen in the 
submandibular  glands  of B10  mice  >7  mo  of age,  large 
infiltrates were never observed in B10 mice even up to 1 yr 
of age (unpublished  observations). 
Time-course of Pancreatic and Submandibular Gland Inflam- 
mation in NOs  b  Mice.  Prospective analysis  of the pan- 
creatic and submandibular  gland inflammation  was carried 
out on male and female NOD.H-2  s (N12) mice at  2,  4,  6, 
and 8 mo of age. The development and severity of the inflam- 
matory responses in NOD.H-2  b mice was found to be highly 
influenced by age.  In mice that were 2 mo old, 2/5 females 
and 0/5 males displayed pancreatic infiltrates,  while subman- 
dular gland histology remained within normal limits in all 
mice. At 4 mo of age,  1/5 females and 1/5 males had pan- 
creatic infiltrates while 4/5 females had developed sialitis.  By 
Figure 4.  Submandibular  gland histology of a female NOD.H-2  b mouse. Extensive mononuclear cell infiltrates are seen in the mixed serous-mucous 
component of the gland.  Lymphatic  vessels are distended  by the resident  lymphocytes  contained  within.  Hematoxylin and  eosin  (x 50). 
72  Autoimmunity in NOD.H-2  b and  (NOD  x  NOD.H-2b)F1 Mice Figure 5.  Demonstration  of  polar antigen  expression  in a RINm38 cryostat  section  using  indirect  immunoperoxidase  histochemistry.  Dense  intracel- 
lular inclusions are typically  seen at the secretory  pole of the insulinoma  cells (x 200). 
6 mo of age, a majority of male and female mice exhibited 
mild to moderate levels of inflammation in the pancreas and/or 
submandibular glands. 8-mo-old mice of both sexes nearly 
always displayed abnormal lymphoid accumulations in the 
pancreas and/or submandibular glands, and many of the mice 
had extensive areas of pathology (Table 2). A time-course for 
submandibular gland pathology, similar to that detailed above 
for the NOD.H-2  b strain, was also seen in NOD mice from 
the current study (data not shown) and in a recent publica- 
tion  (12). 
Detection of  Autoantibodies Recognizing the Polar  Antigen in 
NOI~H-2  a  Mic~  In sera from 30% of new onset type 1 di- 
abetic human patients and of prediabetics, but not of control 
subjects, autoantibodies have been detected which bind to 
the rat insulinoma line ILINm38 in a polar fashion, i.e., cy- 
toplasmic binding that is typically observed at the secretory 
pole of the insulinoma cells (13).  In recent onset diabetics, 
the presence of antipolar antibodies was independent of the 
presence of cytoplasmic islet cell antibodies or of antiinsulin 
autoantibodies. The polar antigen-containing cells are usu- 
ally at the periphery of islet tumor cell dusters, often adja- 
cent to blood vessds or to fibrous connective tissue. The polar 
antigen is pronase sensitive,  but  acetone-, methanol-,  and 
neuraminidase-resistant, suggesting it is a protein. Polar au- 
toantibodies are also present in 100% of NOD mice >1 wk 
and <6 mo of age, but are not observed in normal inbred 
strains of mice including the B10 strain (13, and unpublished 
results). 
NOD.H-2  b mouse sera were evaluated for the presence of 
polar autoantibodies.  Polar autoantibodies  were found in 21/22 
NOD.H-2  b (N12) mice tested (Fig.  5). These results suggest 
that polar autoantibody production is not spedfic for mice 
with/3  cell destruction,  and that  polar  antibodies do not 
mediate islet destruction. Even though the presence of the 
polar antibody is not diabetes specific, production of the polar 
autoantibodies in NOD.H-2  b mice may be caused by one or 
more of the non-MHC-linked diabetogenic genes which, to- 
gether with the NOD MHC, are responsible for the devel- 
opment of diabetes. 
Time-course of Pancreatic and Submandibular Gland Inflam- 
mation in (NOD  ￿  NOI~H-2b)F1  Mice.  As  we reported 
earlier,  (NOD  x  NOI~H-2b)F1  mice develop  significant 
levels of insulitis and occasionally a small percentage sponta- 
neously become diabetic (1, 5). Thus, one dose of the NOD 
MHC confers a dominant susceptibility for insulitis and dia- 
betes, however, there is only a low penetrance ('~3%)  for 
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(NOD  ￿  NOD.H-2S)F1 Mice 
No.  with  insulitis/total 
(NOD  x 
Age  Sex  NOD  NOD.H-2b)F1 
wk 
6  F  2/3  ND 
6  M  2/3  ND 
8  F  3/3  0/10 
8  M  3/3  1/10 
16  F  3/3  0/10 
16  M  3/3  2/10 
24  F  3/3  5/10 
24  M  2/3  1/10 
32  F  2/3  6/10 
32  M  3/3  5/10 
All mice were not diabetic  at  the time of the analysis.  Each group of 
10 male and female (NOD  x  NOD.H-2S)FI mice were composed of five 
(NOD  x  NOD.H-2b)F1  and  five (NOD.H-2  b  x  NOD)Ft mice. 
the diabetes  phenotype in  (NOD  x  NOD.H-2b)F1  mice. 
The time-course  for the development  of insulitis  in (NOD 
x  NOD.H-2b)F1 mice was compared with that of the NOD 
parental  strain (Table 3). Although insulitis was observed as 
early as 8 wk of age in (NOD  x  NOD.H-2b)F1 mice, it was 
a rare event compared with the nearly  complete incidence 
of insulitis in NOD mice at 6 and 8 wk. In addition,  nearly 
all NOD mice display widespread insulitis  between 2 and 
4 mo of age, while (NOD  x  NOD.H-2b)F1 mice developed 
insulitis  comparatively  slowly,  since only 3/40 (NOD  x 
NOD.H-2b)F1 mice g4 mo of age exhibited insulitis.  In ad- 
dition,  the total incidence of insulitis is only •50%  in (NOD 
x  NOD.H-2b)FI  mice  as  compared  with  >95%  in  the 
NOD strain.  Thus in (NOD  x  NOD.H-2b)FI mice,  islet 
pathology is very heterogeneous,  ranging from no insulitis 
to widespread  insulitis  (Fig. 6). These observations  suggest 
that the penetrance of a single dose of the NOD MHC varies 
in individual  mice. 
Cyclophospharaide  Induces  Diabetes  in  (NOD  ￿ 
NOI~H.2~)FI but Not NOI~H-2  b  Mice  Cyclosphosphamide 
increases the rapidity and incidence of diabetes in the NOD 
mouse. However, it does not cause normal strains  of mice 
to develop insulitis  or diabetes (14, 15). It is likely that cy- 
clophosphamide disrupts the established regulatory balance 
Figure 6.  Pancreatic histology of a female (NOD  x  NOD.H-2b)F1 mouse showing moderate  to severe insulitis.  Hematoxylin and eosin (x 125). 
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(NOD  ￿  NOD.H-2b)FI  Mice but Not in NOD.H-2 b Mice 
No. diabetic/ 
Strain  Sex  total  treated 
(NOD  x  NOD.H-2~)F1  Female  13/56 (23%) 
(NOD  x  NOD.H-2b)F1  Male  4/24 (17%) 
NOD.l-l-2  ~  Female  0/17 
NOD.H-2  b  Male  ND 
NOD  Female  8/9 (89%) 
NOD  Male  19/26 (73%) 
Mice received 200 mg/kg of cyclophosphamide  intraperitoneally on days 
0 and 14. Mice were nondiabetic and 6-9 mo of age at the time of cy- 
dophosphamide treatment. Diabetes was confirmed by histologic exami- 
nation of the pancreas. 
of the immune system and allows the existing, although dor- 
mant, effectors of the autoimmune response to be reactivated. 
We  therefore  treated  both  NOD.H-2  b  and  (NOD  x 
NOD.H-2b)F1 mice with cyclophosphamide to determine if 
either  insulitis  or  diabetes could be enhanced.  Of the  17 
NOD.H-2 b female mice treated, insulitis was not observed, 
and none of the 17 developed diabetes (Table 4). This data 
suggests that despite the rare occurrence of mild insulitis in 
NOD.H-2 b mice, this strain is not capable of generating 
cell-specific effectors even after treatment with cyclophospha- 
mide.  In contrast,  23 and 17% of female and male (NOD 
x  NOD.H-I~)F1  mice,  respectively,  developed  diabetes 
when treated with cyclophosphamide. These results suggest 
that  the insulitic infiltrates  in F1 mice contain T  cells  that 
can become effectors of/3 cell destruction and that these cells 
are normally held in check in the (NOD  x  NOD.H-2b)F1 
environment. 
Discussion 
An MHC-linked diabetogenic gene,  Idd-1, was the first 
NOD chromosomal region identified as essential for the de- 
velopment of diabetes in the NOD mouse (1, 4, 16). It was 
also clear from these studies that regions outside the MHC 
contribute to the development of diabetes in the NOD mouse 
(1,  4,  16).  In  a backcross of (NOD  x  NON)F1  mice to 
NOD,  a  non-MHC-linked  diabetogenic  gene,  Idd-2,  was 
identified on chromosome 9 (4). More recently, in an out- 
cross with the BIO.H-2g 7 strain  followed by a backcross to 
the NOD parental strain,  three additional diabetogenic genes, 
Idd-3, -4, and -5, were localized to chromosomes 3, 11, and 
1, respectively (2, 3). Our long-term goal is to develop NOD 
strains  that  have B10-derived alleles  at each of the Idd loci 
identified in the outcross with B10.H-2gL  Such strains will 
be invaluable in deciphering the role each diabetogenic locus 
plays in the development of diabetes and other autoimmune 
manifestations  in the NOD  mouse. 
The NOI~H-2 b strain described in the current study could 
more accurately be termed the NOD.BIO-Idd-I b strain, since 
the number and nature of the MHC-linked diabetogenic genes 
ascribed to Idd-1 remains to be defined. Thus, this strain car- 
ries NOD alleles at all loci contributing  to diabetes except 
Idd-I. We have demonstrated that this strain develops abnor- 
malities not commonly associated with other strains of mice. 
In particular,  lymphoid accumulations in the pancreas and 
the submandibular glands were seen in mice as young as 2 mo 
of age. These abnormalities increased in frequency and severity 
with  age  with  nearly  all  NOD.H-2 b mice  showing  such 
pathology by 8 mo of age. 
The pathology seen in the NOD.H-2 b pancreas was par- 
ticularly striking. Large accumulations of lymphocytes were 
present  and in some cases surrounded the islets.  However, 
few, if any, lymphocytes actually penetrated into  the islets 
making even mild insulitis a rare occurrence. These observa- 
tions have led us to hypothesize that  non-MHC  genes on 
the NOD background cause a general failure in self-tolerance, 
and that one or more self-proteins within the pancreas and 
submandibular glands become the target(s)  of an autoimmune 
response.  Presumably  these  self-proteins  are  processed  in 
antigen-presenting cells, and the resulting peptides bound and 
presented on MHC class II molecules to self-reactive  T cells. 
In  the  NOD  mouse,  the class  II  gene product  efficiently 
presents a B cell-derived peptide which stimulates a B cell- 
specific autoimmune response, while the class II product in 
the NOD.H-2  ~ strain does not present an equivalent ~  cell- 
derived epitope. Alternatively,  the non-MHC diabetogenic 
genes of the NOD may cause or allow lymphocytes to ac- 
cumulate in the pancreas and submandibular glands, and only 
in the NOD mouse does a unique class II peptide complex 
stimulate a specific autoimmune response. Data supporting 
the first hypothesis include the description of autoantibodies 
specific for salivary ducts in the NOD mouse (12). Their pres- 
ence suggests that the observed sialitis is at least partially fo- 
cused on a specific  antigen  in this gland. 
It is interesting that spontaneous infiltrates of both pan- 
creas and submandibular glands are observed in some strains 
of mice and under certain experimental procedures.  In the 
autoimmune NZB strain,  mononuclear cell infiltrates  have 
been identified in the lung, liver, kidney, salivary glands, mesen- 
tery, and pancreas (17). A second autoimmune strain, MRL/ 
lpr, also develops inflammatory cell infiltrates in the salivary 
glands (18). These lesions are primarily composed of CD4 + 
T cells, many of which express class II antigens. In addition, 
Hayashi et al.  (19) found that aged C57BL/6 mice develop 
spontaneous organ-specific autoimmune lesions in the sali- 
vary glands, kidney, pancreas, lung, and liver. This pathology 
was first observed at 6 too, and increased in incidence and 
severity as  mice  were monitored  up  to  2  yr  of age.  The 
infiltrating cells in the salivary glands were composed mainly 
of CD4 + T cells. These authors hypothesized an age-related 
disruption of regulatory T cells resulting in a breakdown of 
self-tolerance to certain organ-specific antigens. In a cyclosporin 
A-induced model of autoimmunity,  neonatal mice develop 
thyroiditis, insulitis,  adrenalitis,  sialitis, oophoritis or orchitis, 
75  Wicker  et al. and gastritis  (20). With this experimental  system, genetic 
factors appeared to influence the tissues selected for immune 
attack. BALB/c mice developed mainly gastritis and oopho- 
ritis,  whereas  other  organ-specific  autoimmune  diseases 
predominated in other strains. Therefore,  a failure in self- 
tolerance as manifested by a variety of organ-specific autoim- 
mune responses can result from a number of mechanisms: 
various genetic predispositions,  aging, experimental  altera- 
tion of proper thymic education,  etc. 
Thus, from the above discussion, although the develop- 
ment of sialitis and pancreatic infiltrates is not unique to the 
NOD.H-2  b strain, it is likely that the relatively early, spon- 
taneous appearance of such lymphocytic infiltrates in these 
tissues represent the activity of genes responsible for the au- 
toimmune  background in the NOD strain. This autoimmune 
background, in conjunction with the NOD MHC region, 
results in the selective targeting of the pancreatic 3 ceUs for 
destruction. 
The development of the NOD.H-2  b strain has also enabled 
us to examine the effect of a single dose of the NOD MHC 
in the presence of NOD homozygosity at all of the non-MHC 
diabetogenic loci. Depending on the phenotype examined in 
the (NOD  x  NOD.H-2b)F1, we observed that the NOD 
MHC can be considered dominant with high penetrance 
(insulitis), dominant with moderate penetrance (cyclophos- 
phamide-induced diabetes), or dominant with low penetrance 
(spontaneous diabetes). Therefore, the NOD MHC clearly 
is active when present at a single dose suggesting  that the 
3  cell-derived  peptide  mentioned above is  able  to  asso- 
ciate with  the  NOD  class II  product  in  the  (NOD  x 
NOD.H-2b)F1 strain. However, the islet-specific  immune re- 
sponse is more protracted as evidenced by the dday in the 
onset of insulitis in those (NOD  x  NOD.H-2~)F1 mice that 
eventually develop pathology (Table  3). Conceivably, reduced 
surface expression of  pathogenic NOD class II-3 cell peptide 
complexes is achieved on antigen-presenting  ceils of (NOD 
x  NOD.H-2b)F1 as compared with NOD, resulting in a less 
vigorous autoimmune response. A recent report from Living- 
stone et al. (21) suggests that the NOD MHC has a higher 
penetrance for spontaneous diabetes in combination with the 
H-2q haplotype.  In  their study,  3/19  diabetic  (NOD  x 
SWR)F1  x  NOD first backcross mice were MHC hetero- 
zygotes. It is possible that the concentration of the patho- 
genic NOD class II-3 cell peptide complexes is higher in 
H-2q/e  r than in H-2b/r  7 antigen-presenting  cells. 
It is intriguing that while spontaneous diabetes is rare in 
(NOD  x  NOD.H-2b)F1  mice (1,  5),  cyclophosphamide- 
induced diabetes occurs in •25%  of the treated mice (Table 
4). This suggests that cyclophosphamide modulates an im- 
mune regulatory event that  normally slows or stops  the 
progression  of insulitis  in  the  (NOD  x  NOD.H-2b)Ft 
strain. The observation that cyclophosphamide treatment of 
NOD.H-2  s mice did not result in widespread insulitis or di- 
abetes (Table 4) is consistent with the hypothesis that in the 
absence of  at least one dose of the NOD MHC, 13 cell-specific 
autoimmune T cells are not generated and thus cannot be 
upregulated  by cyclophosphamide. 
It is interesting to compare the NOD.H-2  b  congenic strain 
with the NOD.N-H-2K b strain described by Prochazka et 
al. (22). The MHC of this congenic strain was derived from 
the NON strain which expresses  in I-E product. In this MHC 
congenic strain, only focal aggregates of leukocytes were de- 
tected and occasionally some of the aggregates were observed 
adjacent to an islet. This minimal pathology seen in 10-mo- 
old NOD.N-H-2K b mice contrasts  sharply with the exten- 
sive accumulations of T cells observed in older NOD.H-2  b 
mice.  Perhaps  the  presence  of  an  I-E  product  in  the 
NOD.N-H-2K b strain reduces the level of the non-/$ cell- 
specific  autoimmune  response  as  compared  with  the 
NOD.H-2 b strain which does not express an I-E product. A 
dramatic reduction in the incidence of insulitis and diabetes 
in NOD mice expressing an I-E transgene has been reported 
by several groups (23, 24). 
The observation that NOD.H-2  b mice produce polar au- 
toantibodies emphasizes the potential utility of constructing 
congenic strains for each of the non-MHC diabetogenic genes 
involved in this complex disease. Since NOD.H-2  b mice do 
not develop insulitis or diabetes but still produce polar au- 
toantibodies,  the presence of polar antibodies does not ap- 
pear to reflect an ongoing/$ cell-specific  autoimmune response 
for expression. Thus, the polar antibody phenotype may be 
a subclinical or nonpathogenic manifestation of a genetic ab- 
normality common to both NOD mice and human diabetics 
that contributes to overt disease  by a currently undefined mech- 
anism. If the NOD allele is replaced by the B10 allele at one 
of the non-MHC-linked diabetogenic loci, and production 
of polar  antibodies is absent,  this phenotype may act as a 
functional marker for that diabetogenic gene. 
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